Use Reciprocal Public License or new license

[Ernest Prabhakar]

Hi Paul,

On Mar 19, 2004, at 7:29 AM, Fearn, Paul A./Urology wrote:

> After reviewing the existing approved licenses, our
> team thought the Reciprocal Public License 1.1 meets
> our needs, however our industrial affairs team wanted
> to make some small changes.
>
> Could you let me know if these 4 changes are reasonable,
> or if we need to go through the new license approval process?

Well, I think that's two different questions.

The changes certainly seem reasonable, and making it more 
explicit/symmetric by saying "including Licensor" shouldn't hurt OSD 
compliance.

However, I don't know the threshold for when the OSD board needs to 
make an affirmative statement.  I suppose it depends on what you're 
looking for.

Do you want your new license posted on our website, and the ability to 
advertise OSD compliance? Are you participating in contractual 
agreements that require OSD compliance?  Do you want the original RPL 
authors to adopt your changes?  Or do you just want the warm fuzzy 
feeling that you're doing the right thing by the community?

-- Ernie P.
IANAL, TINLA, etc.


>
> Thanks,
> Paul Fearn
> ------------------------------------
>
> Reciprocal Public License
> Version 1.1, November 1, 2002
>
> -------------------------------------
> 1. Does the copyright statement at top of license need to
> stay as
>
> "Copyright (C) 2001-2002
> Technical Pursuit Inc.,
> All Rights Reserved."
>
> or should it be changed to this?
>
> "Copyright (C) 2004
> Caisis Team, Memorial Sloan-Kettering Cancer Center,
> All Rights Reserved."
>
> ------------------------------------
>
> 2. In Preamble paragraph 2, our industrial affairs team wanted
> to add the "including Licensor" phrase after "third parties"?
> Would this require creating a new license?
>
> "This License is based on the concept of reciprocity. In exchange for
> being granted certain rights under the terms of this License to
> Licensor's Software, whose Source Code You have access to, You are
> required to reciprocate by providing equal access and rights to all
> third parties [including Licensor] to the Source Code of any
> Modifications, Derivative Works, and Required Components for execution
> of same (collectively defined as Extensions) that You Deploy by
> Deploying Your Extensions under the terms of this License. In this
> fashion the available Source Code related to the original Licensed
> Software is enlarged for the benefit of everyone.
>
> --------------------------------------
>
> 3. In Preamble item c from this section
> "Under the terms of this License You may:," the group also
> wanted to add the "including Licensor" phrase.
>
> "c. Create Extensions to the Licensed Software consistent with the
> rights granted by this License, provided that You make the Source Code
> to any Extensions You Deploy available to all third parties [including
> Licensor], under the terms of this License, document Your Modifications
> clearly, and title all Extensions distinctly from the Licensed
> Software."
>
> --------------------------------------
> 4. Are these changes to Exhibit A correct?
>
> Copyright (C) 1999-2004  P.Alli,  J.Fajardo,  P.Fearn, D.Kuo, K.Regan,
> F.Sculli ("Caisis Team"), Memorial Sloan-Kettering Cancer Center,  All
> Rights Reserved.
>
> Unless explicitly acquired and licensed from Licensor under the MSKCC
> Software Transer Agreement("STA"), the contents of this file are 
> subject
> to  the Reciprocal Public License ("RPL") Version 1.1, or subsequent
> versions as allowed by the RPL, and You may not copy or use this file 
> in
> either  source code or executable form, except in compliance with the
> terms and conditions of the RPL.
>
> You may obtain a copy of both the STA and the RPL (the "Licenses") at
> http://www.cancerdb.org.
>
>
>
>
>
>
>      
> =====================================================================
>
>      Please note that this e-mail and any files transmitted with it 
> may be
>      privileged, confidential, and protected from disclosure under
>      applicable law. If the reader of this message is not the intended
>      recipient, or an employee or agent responsible for delivering this
>      message to the intended recipient, you are hereby notified that 
> any
>      reading, dissemination, distribution, copying, or other use of 
> this
>      communication or any of its attachments is strictly prohibited.  
> If
>      you have received this communication in error, please notify the
>      sender immediately by replying to this message and deleting this
>      message, any attachments, and all copies and backups from your
>      computer.
>
> --
> license-discuss archive is at http://crynwr.com/cgi-bin/ezmlm-cgi?3

--
license-discuss archive is at http://crynwr.com/cgi-bin/ezmlm-cgi?3